This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jun. 7, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management


Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel

 



 Genomics

Doctors try to make sense of cancer's genetic jumble
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not too long ago, knowing the organ where a cancer first takes hold was generally all a doctor needed to determine what treatments to use. Not anymore. Advances in understanding cancer at the molecular level mean doctors can better select the drugs that will most help individual patients. To do so, they must identify which genetic mutations are driving the growth of a patient's tumor, and that shift is making their work much harder. More

What is the Health Economic Impact of a Non-Invasive Prenatal Test?

Learn About Bridgehead International’s report, authored by Susan Garfield, on the clinical and economic utility of this test in this quarter’s JMCM, entitled “Clinical and Cost Consequences of Incorporating a Novel Non-Invasive Prenatal Test into the Diagnostic Pathway for Fetal Trisomies.


'Female' gene to blame for migraines
Daily Mail    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A "female" gene may be to blame for migraine — explaining why women are more likely to suffer from the debilitating headaches, research shows. A study found a new region on the X chromosome as having a link to migraines, providing new evidence their might be a "susceptibility" gene involved. More

Study: Black girls don't benefit as much from exercise
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In a new study of U.S. preteen and teen girls, daily exercise was strongly linked to weight and obesity in white girls but not black girls. Although it's still important to promote physical activity in all young people, according to the researchers that may not be enough to prevent black girls — who have a higher rate of obesity to begin with — from gaining weight. More

 Biotech/Diagnostics/Personalized Medicine


Gene test model may help in non-small cell lung cancer
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A multicenter study in Germany might point the way to better access to personalized medicine for patients with non-small cell lung cancer, a researcher said. While clinical research has found several genetic variants that could guide therapy for the disease, access to testing for them is often restricted to patients treated in large academic centers. More

The 'smart bomb' therapy that blasts breast cancer
This Week    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers are excited about a new cancer therapy that explicitly targets breast cancer cells while leaving healthy ones alone. The experimental "smart bomb," which attaches directly to tumors before killing them, is being hailed as "a major step forward" in the fight against cancer and could potentially reach the market within a year. More


Nursing@
Georgetown


Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies.
MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE


 Regenerative Medicine


Researchers working to repair brain injuries
The Tampa Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers are experimenting with the use of hyperbaric chambers and stem cells to treat traumatic brain injury. They're working with rats, treating them after a brain injury, then examining them for signs of change. But they expect to connect the dots all the way to apply their findings to veterans, stroke victims and others who've suffered brain trauma. More

Scientists report potential impact of olfactory stem cells as therapy
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A study characterizing the multipotency and transplantation value of olfactory stem cells, as well as the ease in obtaining them, has been published in a recent issue of Cell Transplantation. According to the study, olfactory neural stem cells can be derived from a patient's own cells, they are readily available by a minimally invasive biopsy technique, and they can be expanded in vitro. More

 Emerging Medical Technologies


Controlling high blood pressure, through the kidney
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Medical-device makers have rallied to a new experimental treatment for stubborn hypertension: Singeing the walls of nerve-lined arteries leading to the kidneys, blocking the organs' ability to raise blood pressure. Little evidence yet backs the treatment, but initial clinical trials including fewer than 300 patients have shown that the "renal denervation" procedure significantly lowers blood pressure in some patients. More

Trial of 'touchless' gaming technology in surgery
BBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Doctors in London are trialing "touchless" technology, often used in TV games, to help them carry out delicate keyhole surgery. The system allows them to manipulate images with their voice and hand-gestures rather than using a keyboard and mouse. More

 Managed Healthcare News


Most dual eligible care still paid for under FFS model
Healthcare Finance News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study found that most low-income people dually eligible for both Medicare and Medicaid continue to receive benefits separately via fee-for-service arrangement and that gaps in data may hinder deliberations on how to effectively manage care for this population. More

Doctors often order tests, recommend treatment when they shouldn't
Consumer Reports via The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Doctors often order tests and recommend drugs or procedures when they shouldn't — sometimes even when they know they shouldn't. The problem has become so serious that such groups as the American College of Physicians and the National Physicians Alliance and others have compiled lists of tests and treatments that doctors themselves say are done too often. More

 FDA: New Treatments and Technology


FDA to let women try new breast drugs earlier
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Regulators are moving the goal posts in testing new drugs for breast cancer in the hopes of giving more women with aggressive, early-stage cancers the chance to try breakthrough drugs while they have the best shot at a cure. More

FDA rejects Merck's bone cancer treatment
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Merck said the Food and Drug Administration rejected its new drug application for an investigational maintenance treatment for patients with metastatic soft tissue or bone sarcoma. The company said it received a complete response letter from the FDA, which said further clinical trials of the treatment — ridaforolimus — would be needed to assess its effectiveness and safety before any potential approval. More

FAST FACTS
"Bone cancer is rare, and about 2,890 new cases of bone cancer will be diagnosed in 2012, with about 1,410 deaths expected, according to the American Cancer Society."
 
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
June 7, 2012
May 31, 2012
May 24, 2012
May 17, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063